Skip to main content
. 2017 Nov 13;12(11):e0187722. doi: 10.1371/journal.pone.0187722

Fig 5. Distributions of misclassification rates within 1000 iterations of training and validation using 'cancerclass', performed on DLBCL patients' and healthy controls' miRNA profiles (A) or HL patients' and healthy controls' profiles (B).

Fig 5